Background

MicroRNAs (miRNAs) are considered to play a key role in the pathogenesis of myelodysplastic syndromes (MDS). However, the effect of miRNA and targeted mRNA on signal transduction is not fully understood in MDS.

Objective

The objective of this study is to identify the miRNAs-regulated pathways.

Methods

Affymetrix GeneChip microRNA and PrimeView Array were used to analyze miRNAs and gene expression profile of CD34+ cells in 12 MDS patients and 6 healthy controls. Comprehensive bioinformatics analysis of the coordinate expression of miRNAs and mRNAs including Difference, Go, Pathway, Pathway-network, miRNA-Gene-Network and miRNA-Go-Network analysis was performed to identify the miRNAs-regulated networks.

Results

1. 34 differentially expressed miRNAs (5 up- and 29 down-regulated miRNAs) and 1783 mRNAs (405 up- and 1378 down-regulated mRNAs) in CD34+ cells from MDS and Healthy controls were identified by miRNA and mRNA microarray, respectively (Fig.1).

2. 25 dysregulated miRNAs and 234 targeted mRNAs were identified by a combination of Pearson's correlation analysis and prediction by TargetScan; 394 target relationship of miRNAs was established (Fig.2).

3. Go analysis revealed that these miRNA-mRNAs pairs were involved in signal transduction, apoptotic process, DNA-dependent transcription regulation, protein phosphophoration, etc. Pathway analysis showed that MAPK, JAK/STAT and PI3K/Akt signaling pathways might be regulated by these miRNA-mRNAs pairs (Fig.3).

4. The pathway-network analysis revealed that MAPK signaling pathway, Jak-Stat signaling pathway and apoptosis signaling pathway (displayed by red cycle) located in the downstream of signal networks (Fig. 3E). Dysregulation of These pathways may be more meaningful for explaining the pathogenesis of MDS.

5. Through a combination of Pathway, miRNA-Gene-Network and miRNA-Go- Network analysis, 29 miRNA-mRNA-regulated pathways were identified such as miR-148a/TEK/PI3K-Akt signaling pathway, miR-195/BDNF/MAPK signaling pathway, miR-195/DLL1/Notch signaling pathway, miR-145/CCND2/ JAK-STAT signaling pathway, etc. (Table 1).

Conclusion

Alteration expression of several miRNAs and targeted mRNAs might have an important impact on cancer-related cellular pathways including MAPK, PI3K/Akt, JAK/STAT, etc. The role of these miRNAs-mediated pathways in pathogenesis of MDS merit further investigation.

Fig. 1

Affymetrix mcroRNA and mRNA microarray in MDS

Fig. 1

Affymetrix mcroRNA and mRNA microarray in MDS

Close modal
Fig. 2

Significant miRNA-mRNA pairs identified through a integration of mcroRNA-mRNA microarray

Fig. 2

Significant miRNA-mRNA pairs identified through a integration of mcroRNA-mRNA microarray

Close modal

Table 1.

Parts of dysregulated miRNAs, genes and targeted pathway in MDS

MicroRNAStyleGene_synbolPathway
miR-148a  Down TEK PI3K-Akt signaling pathway 
ITGA9 PI3K-Akt signaling pathway 
KIT PI3K-Akt signaling pathway 
HMGA2 Transcriptional misregulation in cancer 
miR-145  Down HHEX Transcriptional misregulation in cancer 
MEIS1 Transcriptional misregulation in cancer 
miR-200c  Down EFNA1 PI3K-Akt signaling pathway 
KLF3 Transcriptional misregulation in cancer 
miR-195  Up BDNF MAPK signaling pathway 
CDC25B MAPK signaling pathway 
DLL1 Notch signaling pathway 
MRAS MAPK signaling pathway 
miR-17 Up CAMK2D Calcium signaling pathway 
miR-19a  Up MAML1 Notch signaling pathway 
SLC8A1 Calcium signaling pathway 
THBS1 Proteoglycans in cancer 
TNF MAPK signaling pathway 
TNFRSF1B Adipocytokine signaling pathway 
ACSL1 Adipocytokine signaling pathway 
EDNRB Calcium signaling pathway 
miR-19b  Up CALM1 Calcium signaling pathway 
TNF Proteoglycans in cancer 
MicroRNAStyleGene_synbolPathway
miR-148a  Down TEK PI3K-Akt signaling pathway 
ITGA9 PI3K-Akt signaling pathway 
KIT PI3K-Akt signaling pathway 
HMGA2 Transcriptional misregulation in cancer 
miR-145  Down HHEX Transcriptional misregulation in cancer 
MEIS1 Transcriptional misregulation in cancer 
miR-200c  Down EFNA1 PI3K-Akt signaling pathway 
KLF3 Transcriptional misregulation in cancer 
miR-195  Up BDNF MAPK signaling pathway 
CDC25B MAPK signaling pathway 
DLL1 Notch signaling pathway 
MRAS MAPK signaling pathway 
miR-17 Up CAMK2D Calcium signaling pathway 
miR-19a  Up MAML1 Notch signaling pathway 
SLC8A1 Calcium signaling pathway 
THBS1 Proteoglycans in cancer 
TNF MAPK signaling pathway 
TNFRSF1B Adipocytokine signaling pathway 
ACSL1 Adipocytokine signaling pathway 
EDNRB Calcium signaling pathway 
miR-19b  Up CALM1 Calcium signaling pathway 
TNF Proteoglycans in cancer 

Fig. 3

Go and pathway analysis

Fig. 3

Go and pathway analysis

Close modal
Disclosures

No relevant conflicts of interest to declare.

Author notes

*

Asterisk with author names denotes non-ASH members.

Sign in via your Institution